Abstract
Antioxidant potential of some β-ionyl compounds has been assessed by examining their ability to protect methyl linoleate from aerial and 2,2-azobisisobutyronitrile-induced radical-mediated oxidation. It is observed that the π- electron density of β-ionyl structure is an important factor in the antiradical activity of these compounds.
Keywords: β-Ionone, retinoids, antiradical, antioxidants, radioprotectants, peroxidation, methyl linoleate, AIBN
Letters in Organic Chemistry
Title: Antiradical Activity of β-Ionyl Compounds
Volume: 7 Issue: 4
Author(s): Anil K. Singh and Solomon B. Libsu
Affiliation:
Keywords: β-Ionone, retinoids, antiradical, antioxidants, radioprotectants, peroxidation, methyl linoleate, AIBN
Abstract: Antioxidant potential of some β-ionyl compounds has been assessed by examining their ability to protect methyl linoleate from aerial and 2,2-azobisisobutyronitrile-induced radical-mediated oxidation. It is observed that the π- electron density of β-ionyl structure is an important factor in the antiradical activity of these compounds.
Export Options
About this article
Cite this article as:
K. Singh Anil and B. Libsu Solomon, Antiradical Activity of β-Ionyl Compounds, Letters in Organic Chemistry 2010; 7 (4) . https://dx.doi.org/10.2174/157017810791130603
DOI https://dx.doi.org/10.2174/157017810791130603 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Anticancer Potential of Ginger: Mechanistic and Pharmaceutical Aspects
Current Pharmaceutical Design Polypharmacology of Approved Anticancer Drugs
Current Drug Targets Pharmacological Modulation of Th17
Recent Patents on Inflammation & Allergy Drug Discovery MYC as Therapeutic Target for Embryonal Tumors: Potential and Challenges
Current Cancer Drug Targets Recent Advances in the Development of Thalidomide-Related Compounds as Anticancer Drugs
Current Medicinal Chemistry PET Imaging for Gene & Cell Therapy
Current Gene Therapy Understanding Mouse Skin Carcinogenesis through Transgenic Approaches
Current Genomics Functional Nanoplatforms for Enhancement of Chemotherapeutic Index
Anti-Cancer Agents in Medicinal Chemistry Potential Gene Therapy Strategies for Cancer Stem Cells
Current Gene Therapy Infection, Stem Cells and Cancer Signals
Current Pharmaceutical Biotechnology The p53-Estrogen Receptor Loop in Cancer
Current Molecular Medicine Adenoviral Vector-Mediated Gene Transfer for Human Gene Therapy
Current Gene Therapy Ligament and Tendon Repair through Regeneration Using Mesenchymal Stem Cells
Current Stem Cell Research & Therapy Baculovirus Gene Delivery: A Flexible Assay Development Tool
Current Gene Therapy Tobacco, Inflammation, and Respiratory Tract Cancer
Current Pharmaceutical Design An Overview of Galenic Preparation Methods for Medicinal Cannabis
Current Bioactive Compounds Therapeutic Intervention in Cancer and Chronic Viral Infections: Antibody Mediated Manipulation of PD-1/PD-L1 Interaction
Reviews on Recent Clinical Trials Anti-Apoptotic Mechanisms of Drug Resistance in Cancer
Current Cancer Drug Targets Emerging Breast Cancer Biomarkers
Current Cancer Therapy Reviews Neuroblastoma and Stem Cell Therapy: An Updated Review
CNS & Neurological Disorders - Drug Targets